Press Release – Collaboration with I-Stem on ASD and DM1

Posted by | No Tags | news | Comments Off on Press Release – Collaboration with I-Stem on ASD and DM1

Ksilink initiates 2 new drug discovery programs on Muscular Dystrophy-1 (DM1) and Autism Spectrum Disorders (ASD) with its strategic partner I-Stem. Click here to download the press release.


No Comments

Comments are closed.